Frank Steven 4

What Happened
Frank Steven, a director of Precigen, was granted company equity on March 10, 2026. The filing reports three acquisitions: 14,245 common shares issued in lieu of a $50,000 annual cash retainer (priced at $3.51 each), plus two restricted stock unit (RSU) awards totaling 76,685 RSUs (35,612 and 41,073) reported with $0 acquisition price. The RSUs are derivative awards representing the right to receive one share each upon vesting.

Key Details

• Transaction date: 2026-03-10; Form 4 filed 2026-03-12 (appears timely under Form 4 rules).
• Grants: 14,245 shares @ $3.51 = $50,000 (issued in lieu of cash retainer).
• RSUs: 35,612 RSUs and 41,073 RSUs granted @ $0.00 (derivative awards), total 76,685 RSUs.
• Vesting: RSUs vest in full on March 10, 2027 (footnote F3).
• Shares owned after transaction: not specified in the filing.
• Transaction code: "A" (award/grant). No 10b5-1 plan, tax withholding, or sale reported in this filing.

Context
This was an equity compensation grant (director retainer settled partly in stock plus RSUs), a routine corporate compensation action rather than an open-market purchase or sale. RSUs are contingent rights to future shares and only become actual shares if and when they vest (here, 3/10/2027). The immediate cash value reported is $50,000 for the shares issued in lieu of the retainer; the RSUs have no immediate cash acquisition price reported but represent additional potential future equity.